Cat. No.: DIA-0231197
Product Information | |
---|---|
CAS No. | 218600-53-4 |
Synonyms | RTA 402, TP-155, NSC 713200, CDDO Methyl Ester |
Formula | C32H43NO4 |
Molecular Weight | 505.69 |
SMILES | COC(=O)C12CCC(C)(C)CC1C3C(=O)C=C4C(C)(CCC5C(C)(C)C(=O)C(=CC45C)C#N)C3(C)CC2 |
Product Description | Bardoxolone Methyl is an IKK inhibitor, showing potent proapoptotic and anti-inflammatory activities. Also a potent Nrf2 activator and nuclear factor-κB (NF-κB) inhibitor. |
Format & Storage | |
---|---|
Purity | > 99% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.